U.S. Physical Therapy, Inc. (NYSE:USPH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $97.50.

A number of brokerages have issued reports on USPH. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, July 24th. Finally, Barrington Research reduced their target price on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, May 13th.

Check Out Our Latest Report on U.S. Physical Therapy

Insider Buying and Selling at U.S. Physical Therapy

In related news, Director Peter Francis Minan acquired 492 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was acquired at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. This trade represents a 20.24% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 2.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada increased its stake in shares of U.S. Physical Therapy by 3.4% in the first quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock valued at $5,733,000 after buying an additional 2,594 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of U.S. Physical Therapy by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after acquiring an additional 391 shares during the period. Jane Street Group LLC boosted its holdings in U.S. Physical Therapy by 249.3% in the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock valued at $3,568,000 after acquiring an additional 35,191 shares during the last quarter. Hsbc Holdings PLC bought a new stake in U.S. Physical Therapy in the second quarter valued at approximately $410,000. Finally, First Trust Advisors LP increased its position in U.S. Physical Therapy by 3.7% during the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock valued at $839,000 after purchasing an additional 385 shares during the period.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $79.89 on Monday. The firm’s fifty day moving average price is $70.17 and its two-hundred day moving average price is $74.15. The stock has a market cap of $1.22 billion, a PE ratio of 469.97, a PEG ratio of 2.18 and a beta of 1.13. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.19 and a current ratio of 1.27. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $93.50.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. During the same quarter in the previous year, the company posted $0.81 earnings per share. The firm’s revenue was up 8.5% on a year-over-year basis. On average, equities analysts expect that U.S. Physical Therapy will post 2.98 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy’s payout ratio is 1,082.35%.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Featured Stories

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.